MedTrace Logo

NASCITA Italian Birth Cohort Study

NCT03894566 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-11-21

No results posted yet for this study

Summary

The NASCITA study (NAscere e creSCere in ITAlia) was created to improve the understanding of the health status of Italian children early on and how it is affected by social and health determinants.

The study will evaluate physical, cognitive, and psychological development, and health status and health resource use during the first six years of life in a group of newborns, as well as potential associated factors. The association between the well-being of children and parental adherence to the recommendations for better child care and development will also be assessed.

Information on the children will be collected by paediatricians mostly during routine visits.

The findings will be used in the development of specific prevention measures and interventions to improve the health of children, in particular more vulnerable ones.

Conditions

  • Social Determinants of Health
  • Health Knowledge, Attitudes, Practice
  • Development, Child
  • Mental Disorders
  • Nutrition Disorders
  • Communicable Diseases

Interventions

OTHER

No intervention - birth cohort study

There are no interventions because it is a birth cohort study

Sponsors & Collaborators

  • Mario Negri Institute for Pharmacological Research

    lead OTHER

Principal Investigators

  • Maurizio Bonati, MD · Istituto Di Ricerche Farmacologiche Mario Negri

  • Antonio Clavenna, MD, PhD · Istituto Di Ricerche Farmacologiche Mario Negri

  • Chiara Pandolfini, BA, PhD · Istituto Di Ricerche Farmacologiche Mario Negri

Eligibility

Max Age
45 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2023-09-30
Completion
2026-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03894566 on ClinicalTrials.gov